Reply to Dr Kawada late-gestation selective serotonin reuptake inhibitor exposure and perinatal mortality
dc.contributor.author | Grzeskowiak, L.E. | |
dc.contributor.author | Morrison, J.L. | |
dc.date.issued | 2014 | |
dc.description | Letters to the Editors. | |
dc.description.statementofresponsibility | Luke E. Grzeskowiak, Janna L.Morrison | |
dc.identifier.citation | Journal of Clinical Psychopharmacology, 2014; 34(6):751-752 | |
dc.identifier.doi | 10.1097/JCP.0000000000000111 | |
dc.identifier.issn | 0271-0749 | |
dc.identifier.issn | 1533-712X | |
dc.identifier.orcid | Grzeskowiak, L.E. [0000-0001-8554-4696] | |
dc.identifier.uri | http://hdl.handle.net/2440/127086 | |
dc.language.iso | en | |
dc.publisher | Lippincott, Williams & Wilkins | |
dc.rights | © 2014 Lippincott Williams & Wilkins | |
dc.source.uri | http://dx.doi.org/10.1097/jcp.0000000000000111 | |
dc.subject | Prenatal Exposure Delayed Effects | |
dc.title | Reply to Dr Kawada late-gestation selective serotonin reuptake inhibitor exposure and perinatal mortality | |
dc.type | Journal article | |
pubs.publication-status | Published |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- hdl_127086.pdf
- Size:
- 330.11 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version